Filter
791
Filtered Results: 791
Text search:
World
Health
Organization,
Regional
Office
for
Eastern
Mediterranean
Featured
Recommendations
118
New Publications
157
Language
Document type
No document type
264
Studies & Reports
210
Guidelines
146
Manuals
66
Strategic & Response Plan
47
Training Material
15
Fact sheets
14
Situation Updates
13
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
77
Syria
24
Africa
21
Middle East and North Africa
19
Western and Central Europe
16
Somalia
11
Yemen
9
South–East Asia Region
8
Latin America and the Carribbean
7
West and Central Africa
7
Sudan
7
Ethiopia
7
Eastern Europe
6
Pakistan
6
Kenya
5
Nigeria
5
East and Southern Africa
5
Liberia
5
Sierra Leone
4
Iran
4
Senegal
4
Afghanistan
4
Jordan
4
Eastern Europe and Central Asia
4
Lebanon
4
Iraq
4
Myanmar / Burma
4
Turkey
3
Ghana
3
Rwanda
3
Asia
3
Venezuela
3
Saudi Arabia
3
India
3
North Macedonia
2
Nepal
2
Thailand
2
Ukraine
2
China
2
Congo, Democratic Republic of
2
Bangladesh
2
South Africa
2
Uganda
2
Libya
2
Mexico
1
Benin
1
Cameroon
1
Albania
1
Burkina Faso
1
Morocco
1
Qatar
1
Philippines
1
USA
1
Cambodia
1
Croatia
1
Tanzania
1
Western Pacific Region
1
Paraguay
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Russia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
Central African Republic
1
Mali
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
115
Countries
97
Public Health
86
Women & Child Health
71
Key Resources
62
Capacity Building
26
Pharmacy & Technologies
15
Toolboxes
Mental Health
89
COVID-19
86
Rapid Response
53
Planetary Health
49
TB
42
HIV
39
NTDs
39
Refugee
33
Caregiver
33
Conflict
33
Global Health Education
30
AMR
29
Disability
24
NCDs
24
Pharmacy
19
Ebola & Marburg
13
Polio
12
Cholera
9
Natural Hazards
7
Zika
7
Health Financing Toolbox
5
Specific Hazards
4
Malaria
3
Social Ethics
1
Typhoon
1
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
The push to immunize all children against polio has been hampered by the ongoing crisis in the Syrian Arab Republic. WHO and UNICEF have appealed to all parties to cooperate, including through temporary pauses in hostilities where needed, to allow vaccination campaigns to take place and for all chil...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
In fragile, conflict-affected and vulnerable settings, delivery of quality health services faces significant challenges, including disruption of a routine health service organization and delivery systems, increased health needs, complex and unpredictable resourcing issues, and vulnerability to multi...
The risk communication and community engagement (RCCE) competency framework is a resource that details the essential behaviours and activities necessary for effective communication and engagement with communities before, during and after public health emergencies. The purpose of this framework is to...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
The report provides a global knowledge base on suicide and suicide attempts as well as actionable steps for countries based on their current resources and context to move forward in suicide prevention.
Updated 20 Nov. 2020
Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of h...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
Provides clinical descriptions, diagnostic guidelines, and codes for all mental and behavioural disorders commonly encountered in clinical psychiatry. The book was developed from chapter V of the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (...
